Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
Clinical trial NCT02996682 · COMPLETED
Trial details
- NCT number
- NCT02996682
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-26
- Primary completion
- 2018-02-13
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.